MDA-19 – synthetic, strong CB2 agonist

 

Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain.

(abst – 2008)                      http://www.ncbi.nlm.nih.gov/pubmed/18666769

 

Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain.      (full – 2010)                                       http://www.anesthesia-analgesia.org/content/111/1/99.long

 

Studies demonstrate analgesic properties of synthetic cannabinoid (news – 2010)  http://www.news-medical.net/news/20100702/Studies-demonstrate-analgesic-properties-of-synthetic-  cannabinoid.aspx

Share a link for